TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

TScan Therapeutics (TCRX) recorded Return on Capital Employed [ROCE] of -98.24% in Q3 2026, down 39.05 percentage points from -59.19% a year earlier and down 20.85 percentage points from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, TScan Therapeutics reported Return on Capital Employed [ROCE] of -48.29%, down 1.09 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three straight years, though with a four-year change of +1.56 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -47.19% in FY2024 (-1.78 pp), -45.41% in FY2023 (-7.61 pp), -37.80% in FY2022 (+12.05 pp) and -49.85% in FY2021.
  • The Q3 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2021.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for six consecutive quarters, with an average year-over-year change of -17.70 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 10.20 percentage points in Q3 2023, against a drop of 39.05 percentage points in Q3 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -77.39% (Q2 2026), -65.86% (Q1 2026) and -59.88% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -5,780.97%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 35.41%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 17.52%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 21.60%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 4.65%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -6.15%
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -98.24%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -98.24%
Jun 30, 2026 -77.39%
Mar 31, 2026 -65.86%
Dec 31, 2025 -59.88%
Sep 30, 2025 -59.19%
Jun 30, 2025 -50.73%
Mar 31, 2025 -43.37%
Dec 31, 2024 -41.66%
Sep 30, 2024 -35.90%
Jun 30, 2024 -41.44%
Mar 31, 2024 -45.37%
Dec 31, 2023 -37.09%
Sep 30, 2023 -33.49%
Jun 30, 2023 -39.30%
Mar 31, 2023 -42.50%
Dec 31, 2022 -40.39%
Sep 30, 2022 -43.69%
Jun 30, 2022 -42.93%
Mar 31, 2022 -35.62%
Dec 31, 2021 -27.77%
API Access

TScan Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TCRX&period=max&api_key=YOUR_API_KEY